Lingual localization of lymphangiomas presents a therapeutic challenge mostly because of the lesions' microcystic characteristics, which make complete surgical excision difficult if not impossible, and because of the functional problems they cause (obstruction, pain, feeding problems, edema, jaw deformities, breathing problems, and bleeding). Partial glossectomies have a high rate of relapse and can result in morphological changes in the tongue; sclerosing agents cannot be used on microcystic lesions. The use of several treatments aiming to resurface microcystic lymphatic lingual lesions with hemorrhagic vesicles, including laser and radiofrequency resurfacing (Coblation [cold plus ablation]; ArthroCare ENT, Austin, Texas), has been reported, sometimes with good results.1
Figure 1. Photographs of patient 1 before and after treatment with cold plus ablation (Coblation; ArthroCare ENT, Austin, Texas) and propranolol. A, At 15 months old, before Coblation. B, At 21 months old, 1 month after Coblation. C, At 36 months old, after recurrence of the symptoms. D, At 39 months old, 1 month after propranolol therapy was initiated. E, At 41 months old, 16 days after propranolol therapy was discontinued, with recurrence of bleeding. F, At 56 months old, the final aspect of the tongue 7 months after propranolol therapy was discontinued.
Figure 2. Patient 2 before (A) and after (B) 2 months of propranolol therapy showing disappearance of bleeding and decreased tongue size.The patient also had improvement in feeding difficulties.
Figure 3. Patient 3 before (A) and after (B) 2 months of propranolol therapy showing slight change in tongue coloration, reduced bleeding, and unchanged tongue size.
Thank you for submitting a comment on this article. It will be reviewed by JAMA Otolaryngology–Head & Neck Surgery editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 3
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.